Dextroamphetamine, commonly prescribed for the treatment of hyperactivity disorders and narcolepsy, is a potent central nervous system agent with a complex pharmacological profile. Understanding its function – primarily impacting dopamine and norepinephrine neurotransmission – is careful consideration due to potential consequences and the risk